Results 1 to 10 of about 1,721,954 (363)
Targeted therapy in melanoma [PDF]
Malignant melanoma is a highly lethal disease unless detected early. Single-agent chemotherapy is well tolerated but is associated with very low response rates. Combination chemotherapy and biochemotherapy may improve objective response rates but do not prolong survival and are associated with greater toxicity.
Hussein Tawbi, Neelima Nimmagadda
openaire +7 more sources
Targeted Therapies for the Neurofibromatoses [PDF]
Over the past several years, management of the tumors associated with the neurofibromatoses has been recognized to often require approaches that are distinct from their spontaneous counterparts. Focus has shifted to therapy aimed at minimizing symptoms given the risks of persistent, multiple tumors and new tumor growth.
Lauren D. Sanchez+2 more
openaire +3 more sources
Targeting in Cancer Therapies [PDF]
Drug developers recruit and combine principles, procedures and strategies from chemistry, pharmacology, nanotechnology and biotechnology, focusing on the generation of functional vehicles as nano-carriers of drugs for improved stability and enhanced intracellular delivery.[...]
Ramon Mangues+2 more
openaire +5 more sources
Targeted therapy in lymphoma [PDF]
AbstractDiscovery of new treatments for lymphoma that prolong survival and are less toxic than currently available agents represents an urgent unmet need. We now have a better understanding of the molecular pathogenesis of lymphoma, such as aberrant signal transduction pathways, which have led to the discovery and development of targeted therapeutics ...
Patrick B. Johnston+3 more
openaire +4 more sources
Targeted Perfusion Therapy in Spinal Cord Trauma. [PDF]
We review state-of-the-art monitoring techniques for acute, severe traumatic spinal cord injury (TSCI) to facilitate targeted perfusion of the injured cord rather than applying universal mean arterial pressure targets.
Papadopoulos, MC, Saadoun, S
core +1 more source
Targeted Therapies for Melanoma [PDF]
The incidence of cutaneous malignant melanoma (CMM) is significantly increasing worldwide.[...]
Karel Smetana+2 more
openaire +3 more sources
Targeted Radionuclide Therapy [PDF]
Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing of cancer cells is achieved with the use of biological vectors and appropriate radionuclides. Among the many advantages of this approach are its selectiveness in delivering the radiation to the target, relatively less severe and infrequent side effects, and the
Indukala Doddamane+2 more
openaire +3 more sources
AbstractTargeted therapy is the key for improving overall survival while decreasing the undesirable adverse effects of cancer treatment. Patients who received matched targeted therapies showed dramatically improved overall survival (OS) and progression-free survival (PFS) compared to those without matched therapies.
Zhijun Zhou, Min Li
openaire +3 more sources
Targeted radionuclide therapy [PDF]
Targeted radionuclide therapy (TRT) seeks molecular and functional targets within patient tumor sites. A number of agents have been constructed and labeled with beta, alpha, and Auger emitters. Radionuclide carriers spanning a broad range of sizes; e.g., antibodies, liposomes, and constructs such as nanoparticles have been used in these studies. Uptake,
Gerald L. DeNardo+2 more
openaire +3 more sources
From ‘Targeted Therapy’ to Targeted Therapy [PDF]
In early 2000, the term 'targeted therapy' became popular and was used to indicate all types of tyrosine kinase inhibitors (TKI). However, the term targeted therapy had been used much earlier. Targeting tumor metabolism was already considered as targeted therapy, with methotrexate and 5-fluorouracil as the most successful examples.
openaire +4 more sources